SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001493152-24-015035
Filing Date
2024-04-17
Accepted
2024-04-17 16:15:40
Documents
3

Document Format Files

Seq Description Document Type Size
1 form424b4.htm 424B4 3152654
2 form424b4_001.jpg GRAPHIC 4937
3 form424b4_002.jpg GRAPHIC 69570
  Complete submission text file 0001493152-24-015035.txt   3256673
Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Filer) CIK: 0001855485 (see all company filings)

IRS No.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-276741 | Film No.: 24851259
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)